- This topic has 0 replies, 1 voice, and was last updated 1 week, 6 days ago by .
-
Posts
-
CurePSP is now accepting Letters of Intent for our new Biomarker Accelerator Program. The Biomarker Accelerator Program will fund projects driving biomarker discoveries to accelerate diagnosis, treatment, research, or clinical care for PSP. The proposed studies should build upon existing discoveries by conducting the next steps needed to move the biomarkers into research or clinical settings. The existing discoveries may come from preclinical models, fluids, tissue, proteomics, imaging, genetic data, or other modalities.
The CurePSP Biomarker Accelerator Program is open to researchers at academic institutions and researchers at small companies (nonprofits and for-profit organizations). Partnership between academia and larger companies is allowed. Investigators can be located in the U.S. or internationally.
The Biomarker Accelerator Program will fund each award up to $500,000 for the duration of the project. No indirect costs are allowed for this program. The proposed award term can be up to three years.
Timeline:
- Letter of Intent Launch: October 15, 2025
- Letter of Intent Deadline: December 15, 2025, 5:00 PM US Eastern Time
- Letter of Intent Decision Notification: By January 31, 2026
- Full Proposal Deadline: March 31, 2026, 5:00 PM US Eastern Time
Full program information is available on our website: https://www.psp.org/biomarker-accelerator-application
- You must be logged in to reply to this topic.